Health Catalyst, Inc. — Form 8-K
Filed September 8, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 72/100
What the filing says
Health Catalyst appointed Simeon Kohl as CEO and President (effective September 14, 2026) with a grant of 2,747,385 RSUs vesting 33.33% at one year then 66.67% quarterly thereafter, plus $600,000 base salary and 100% bonus opportunity. Prior CEO Ben Albert transitions to Chief Business Officer at $415,000 base with 60% bonus (prorated for 2026 at higher rates reflecting prior roles). The company established a 2026 Employment Inducement Incentive Plan (2,747,385 share reserve) to facilitate the executive transition.
Why this rating
Major leadership change (CEO replacement) relative to $259M market cap; 2.7M RSUs = ~1.1% dilution; but neither executive departure nor equity grant materially threatens business continuity or alter trajectory materially.
Price action (we called it neutral)
at our read · unknown $1.69 | +10 min · unknown $1.69 ▲ 0.00% | +30 min · unknown $1.69 ▲ 0.00% | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; sessions other than regular hours are labeled. Not investment advice. How accurate are our calls? →
See more from September 8, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.